Efficacy, Tolerability and Safety of ALNA® in Patients With Benign Prostatic Syndrome (BPS)

Clinical trial NCT02244333 · COMPLETED

Trial details

NCT number: NCT02244333
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Study type: OBSERVATIONAL

Prostatic Hyperplasia

Start date: 2004-02-01
Primary completion: 2004-07-01
Enrollment: 4575

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.